CC BY-NC-ND 4.0 · AJP Rep 2023; 13(04): e78-e81
DOI: 10.1055/s-0043-1777099
Case Report

A Case of Significant Transaminitis with Liver Biopsy in a Pregnant Patient with COVID-19

1   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
Anna Galyean
2   Department of Obstetrics and Gynecology, Southern California Permanente Medical Group, Pasadena, California
Kelvin Nguyen
3   Department of Gastroenterology, Southern California Permanente Medical Group, Pasadena, California
Najeeb Alshak
4   Department of Pathology, Southern California Permanente Medical Group, Pasadena, California
Elizabeth Blumenthal
2   Department of Obstetrics and Gynecology, Southern California Permanente Medical Group, Pasadena, California
› Institutsangaben


Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has led to a global health crisis. The virus can cause varying severity of liver injury, but the mechanism has not yet been elucidated, especially in pregnancy.

We present a morbidly obese 30-year-old woman with COVID-19 at 28 weeks' gestation complicated by significant transaminitis with peak liver enzymes levels of 501/1,313 (aspartate aminotransferase/alanine aminotransferase). Liver biopsy showed reactive changes consistent with medication effect and mild steatosis.

Significant transaminitis has been found in both pregnant and nonpregnant patients with COVID-19. Our case demonstrates the multifactorial nature of liver injury in COVID-19 patients including mild underlying liver steatosis combined with possible viral potentiation of medication effect.


Eingereicht: 23. November 2020

Angenommen: 30. August 2023

Artikel online veröffentlicht:
28. November 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  • References

  • 1 Wang L, He W, Yu X. et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect 2020; 80 (06) 639-645
  • 2 Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020; 14 (04) 303-310
  • 3 Adapa S, Chenna A, Balla M. et al. COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation. J Clin Med Res 2020; 12 (06) 352-361
  • 4 Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020; 17 (09) 543-558
  • 5 Breslin N, Baptiste C, Gyamfi-Bannerman C. et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020; 2 (02) 100118
  • 6 Blitz MJ, Grünebaum A, Tekbali A. et al. Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019. Am J Obstet Gynecol 2020; 223 (02) 290-291
  • 7 Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: a review. J Card Surg 2020; 35 (06) 1302-1305
  • 8 Feng G, Zheng KI, Yan Q-Q. et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol 2020; 8 (01) 18-24
  • 9 Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol 2020; 73 (05) 1231-1240
  • 10 Li Y, Xiao SY. Hepatic involvement in COVID-19 patients: pathology, pathogenesis, and clinical implications. J Med Virol 2020; 92 (09) 1491-1494
  • 11 Creanga AA, Johnson TF, Graitcer SB. et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010; 115 (04) 717-726
  • 12 Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60
  • 13 Chen H, Guo J, Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815
  • 14 Hantoushzadeh S, Shamshirsaz AA, Aleyasin A. et al. Maternal death due to COVID-19. Am J Obstet Gynecol 2020; 223 (01) 109.e1-109.e16
  • 15 Alonso Díaz C, López Maestro M, Moral Pumarega MT, Flores Antón B. Pallás Alonso CR. First case of neonatal infection due to SARS-CoV-2 in Spain. An Pediatr (Engl Ed) 2020; 92 (04) 237-238
  • 16 Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol 2020; 37 (08) 861-865
  • 17 González Romero D, Ocampo Pérez J, González Bautista L, Santana-Cabrera L. Pregnancy and perinatal outcome of a woman with COVID-19 infection [in Spanish]. Rev Clin Esp (Barc) 2020; 220 (08) 533-534
  • 18 Juusela A, Nazir M, Gimovsky M. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy. Am J Obstet Gynecol MFM 2020; 2 (02) 100113
  • 19 Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020; 99 (07) 823-829
  • 20 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
  • 21 Bloom PP, Meyerowitz EA, Reinus Z. et al. Liver biochemistries in hospitalized patients with COVID-19. Hepatology 2021; 73 (03) 890-900
  • 22 Richardson S, Hirsch JS, Narasimhan M. et al; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323 (20) 2052-2059
  • 23 Xu Z, Shi L, Wang Y. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8 (04) 420-422
  • 24 Massart J, Begriche K, Moreau C, Fromenty B. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res 2017; 3 (Suppl. 01) 212-232
  • 25 Michaut A, Moreau C, Robin MA, Fromenty B. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int 2014; 34 (07) e171-e179
  • 26 Myers RP, Shaheen AAM, Li B, Dean S, Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 2008; 6 (08) 918-925 , quiz 837
  • 27 Moling O, Cairon E, Rimenti G, Rizza F, Pristerá R, Mian P. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther 2006; 28 (05) 755-760
  • 28 Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology 2008; 48 (04) 1336-1341